Karl-Heinz Baringhaus obtained his Ph.D. in synthetic organic chemistry at the University of Münster. After a postdoctoral fellowship at Stanford University he joined Hoechst AG in 1990 where he was working six years in Medicinal Chemistry. He then moved into Molecular Modeling and in 2000 became Head of Computational Chemistry at Aventis Pharma. From 2005 to 2010 he was Director of Drug Design at Sanofi-Aventis Pharma Deutschland GmbH. In 2010 he was promoted to Head of Structure, Design & Informatics consisting of Computational Biology & Bioinformatics, Computer-aided Drug Design, Scientific Computing & Data Management as well as Structural Biology. Since 2012, Karl-Heinz has been R&D Site Director in Frankfurt.
